Aleva Neurotherapeutics SA raises 10 Million USD in Series C Financing Round (May 27, 2016).
Aleva Neurotherapeutics SA and Greatbatch Inc announce collaboration for next generation Deep Brain Stimulation System (DBS). Press Release (PDF)
The Michael J. Fox Foundation for Parkinson’s Research, a prestigious association dedicated to finding a cure for Parkinson's disease and funding the development of improved therapies, has awarded Aleva Neurotherapeutics SA with a research grant to support the clinical validation of our Directional DBS System. MJFF Website Announcement / Press Release (PDF)
Aleva Neurotherapeutics SA appoints Dr. Philippe Dro to its Board of Directors (August 28, 2015). Press Release (PDF)
Aleva Neurotherapeutics SA raises 8 Million USD in Series B Financing Round (September 17, 2014).
BRAIN Publication Demonstrates Significantly Improved Therapeutic Window Using directSTIM™ Directional Electrode (May 28, 2014).Press Release (PDF) / Article (PDF) / Editorials (PDF)
Aleva Neurotherapeutics SA demonstrates Clinical Effectiveness Through Directional Deep Brain Stimulation with directSTIM™ (May 30, 2013). Press Release (PDF)
Aleva Neurotherapeutics SA raises 4 Million USD in Series A' Financing Round (April 10, 2012). Press Release (PDF)
Aleva Neurotherapeutics SA raises 10 Million USD in Series A Financing Round (August 25, 2011). Press Release (PDF)
ALEVA NEUROTHERAPEUTICS SA | EPFL INNOVATION PARK - BUILDING D | 1015 LAUSANNE | SWITZERLAND | INFO@ALEVA-NEURO.COM
|CONTACT & DIRECTIONS|